Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
Á. Oteo-Álvaro, Carlos Goicoechea, Alejandra Inocencio Sánchez, C.A Santamarı́a, Javier de Diego-Adeliño
Topics & Concepts
DenosumabMedicineAdverse Event Reporting SystemAdverse effectRANKLInternal medicineOncologyAnxietyPsychiatryBioinformaticsOsteoporosisReceptorActivator (genetics)BiologyBone Metabolism and DiseasesS100 Proteins and AnnexinsCytokine Signaling Pathways and Interactions